• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼移植物抗宿主病伴神经营养性角膜病变患者的眼部疼痛。

Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy.

机构信息

Laboratory of Corneal Immunology, Transplantation and Regeneration, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA.

Laboratory of Corneal Immunology, Transplantation and Regeneration, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA.

出版信息

Ocul Surf. 2022 Oct;26:142-147. doi: 10.1016/j.jtos.2022.07.005. Epub 2022 Aug 7.

DOI:10.1016/j.jtos.2022.07.005
PMID:35948166
Abstract

PURPOSE

Neurotrophic keratopathy (NK) is a degenerative disorder of the cornea characterized by decreased sensory innervation, epitheliopathy, and impaired epithelial healing. In this study, we assessed ocular pain and quality-of-life-related parameters in ocular graft-versus-host disease (oGVHD) patients with and without NK.

METHODS

We included 213 oGVHD patients in this retrospective study, including 29 patients with NK assessed by the Cochet-Bonnet esthesiometer. We evaluated their records for ocular pain assessment survey (OPAS) scores and clinical parameters, including corneal sensation, corneal fluorescein staining (CFS) score, Schirmer's test, tear break-up time (TBUT), and ocular surface disease index (OSDI) score.

RESULTS

oGVHD patients with NK had lower corneal sensation (3.4 ± 1.4 vs. 5.9 ± 0.3; p < 0.0001), higher CFS scores (6.4 ± 4.2 vs. 4.7 ± 4.0; p = 0.01), and lower TBUT scores (1.2 ± 2.1 vs. 2.2 ± 3.1; p = 0.08) compared to oGVHD patients without NK and additionally had significantly higher ocular pain intensity scores (OPAS 24-h average eye pain intensity: 2.0 ± 2.8 vs. 1.1 ± 1.9; p = 0.03). Patients with NK more commonly reported burning (0.2 ± 0.3 vs. 0.3 ± 0.4; p = 0.021) and sensitivity to light (0.2 ± 0.3 vs. 0.3 ± 0.4; p = 0.049) as compared to patients without NK.

CONCLUSION

Clinical signs of ocular surface disease are worse in oGVHD patients with NK compared to oGVHD patients without NK. These patients additionally experience higher intensity ocular pain and lower quality-of-life-related parameters.

摘要

目的

神经营养性角膜病变(NK)是一种以感觉神经支配减少、上皮病变和上皮愈合受损为特征的角膜退行性疾病。本研究评估了伴有和不伴有 NK 的眼移植物抗宿主病(oGVHD)患者的眼部疼痛和生活质量相关参数。

方法

本回顾性研究纳入了 213 例 oGVHD 患者,其中 29 例患者采用 Cochet-Bonnet 触觉计评估 NK。我们评估了他们的记录,包括眼部疼痛评估调查(OPAS)评分和临床参数,包括角膜感觉、角膜荧光素染色(CFS)评分、泪液分泌试验、泪膜破裂时间(TBUT)和眼表面疾病指数(OSDI)评分。

结果

与无 NK 的 oGVHD 患者相比,伴有 NK 的 oGVHD 患者的角膜感觉更低(3.4±1.4 对 5.9±0.3;p<0.0001),CFS 评分更高(6.4±4.2 对 4.7±4.0;p=0.01),TBUT 评分更低(1.2±2.1 对 2.2±3.1;p=0.08),且眼部疼痛强度评分显著更高(OPAS 24 小时平均眼痛强度:2.0±2.8 对 1.1±1.9;p=0.03)。与无 NK 的患者相比,NK 患者更常报告烧灼感(0.2±0.3 对 0.3±0.4;p=0.021)和对光敏感(0.2±0.3 对 0.3±0.4;p=0.049)。

结论

与无 NK 的 oGVHD 患者相比,伴有 NK 的 oGVHD 患者的眼表面疾病临床体征更差。这些患者还经历更高强度的眼部疼痛和更低的生活质量相关参数。

相似文献

1
Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy.眼移植物抗宿主病伴神经营养性角膜病变患者的眼部疼痛。
Ocul Surf. 2022 Oct;26:142-147. doi: 10.1016/j.jtos.2022.07.005. Epub 2022 Aug 7.
2
Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease.慢性眼部移植物抗宿主病患者的神经营养性角膜病变患病率。
Ocul Surf. 2022 Oct;26:13-18. doi: 10.1016/j.jtos.2022.07.001. Epub 2022 Jul 16.
3
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.慢性眼移植物抗宿主病的眼表面指标和生物标志物:一项前瞻性队列研究。
Bone Marrow Transplant. 2021 Aug;56(8):1850-1858. doi: 10.1038/s41409-021-01254-5. Epub 2021 Mar 8.
4
Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.硅酮泪点塞治疗伴或不伴眼移植物抗宿主病患者干眼的疗效和保留率。
Ocul Surf. 2020 Oct;18(4):731-735. doi: 10.1016/j.jtos.2020.07.018. Epub 2020 Jul 30.
5
Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).眼慢性移植物抗宿主病(GVHD)的诊断和严重程度评估中的泪液细胞因子水平。
Ocul Surf. 2020 Apr;18(2):298-304. doi: 10.1016/j.jtos.2019.12.005. Epub 2020 Jan 15.
6
Concurrent ocular pain in patients with neurotrophic keratopathy.神经营养性角膜病变患者的眼部疼痛。
Ocul Surf. 2021 Oct;22:143-151. doi: 10.1016/j.jtos.2021.08.003. Epub 2021 Aug 17.
7
Development and validation of a diagnostic model for the identification of chronic ocular graft-versus-host disease (oGVHD).用于识别慢性眼部移植物抗宿主病(oGVHD)的诊断模型的开发与验证
Front Med (Lausanne). 2023 Oct 27;10:1277194. doi: 10.3389/fmed.2023.1277194. eCollection 2023.
8
Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.眼移植物抗宿主病患者的泪膜免疫特征。
Ocul Immunol Inflamm. 2023 May;31(4):701-709. doi: 10.1080/09273948.2022.2046794. Epub 2022 Apr 11.
9
Clinical outcomes of corneal neurotization using sural nerve graft in neurotrophic keratopathy.神经生长因子诱导角膜感觉神经再生治疗神经营养性角膜病变的临床研究
PLoS One. 2023 Nov 28;18(11):e0294756. doi: 10.1371/journal.pone.0294756. eCollection 2023.
10
Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy.活体共聚焦显微镜观察眼移植物抗宿主病的角膜特征
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2389-2397. doi: 10.1007/s00417-017-3759-x. Epub 2017 Sep 5.

引用本文的文献

1
A Novel Murine Model for Lupus-Like Ocular Chronic Graft-Versus-Host Disease.一种新型狼疮样眼部慢性移植物抗宿主病的小鼠模型。
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):20. doi: 10.1167/iovs.65.6.20.
2
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation.造血干细胞移植后眼移植物抗宿主病的免疫病理机制和临床表现。
Bone Marrow Transplant. 2024 Aug;59(8):1049-1056. doi: 10.1038/s41409-024-02321-3. Epub 2024 May 31.
3
Ocular manifestations and quality of life in patients after hematopoietic stem cell transplantation.
造血干细胞移植术后患者的眼部表现及生活质量
Int J Ophthalmol. 2023 Jul 18;16(7):1138-1144. doi: 10.18240/ijo.2023.07.20. eCollection 2023.